Dr. Reddy's Laboratories Limited RDY
As ofNov 20, 2026, 1:17 PM EST
- YTD
- +6.23%
- 1 year
- +7.30%
Fundamental scorecard
16 of 25 checks passed on RDY’s reported financials
16of 25 checks passed
- Value 1 of 5
- Growth 4 of 5
- Profitability 2 of 5
- Financial health 5 of 5
- Dividend 4 of 5
Statements to Mar 31, 2026.
Value 1 of 5
- Failed:P/E below its own 5-year median P/E 26.1 against a 5-year median of 18.3.
- Failed:P/E under 20 P/E 26.1: an earnings yield of 3.8%.
- Failed:Price to sales below its own 5-year median Price to sales 3.3 against a 5-year median of 3.2.
- Passed:Price to book below its own 5-year median Price to book 3.0 against a 5-year median of 3.4.
- Failed:Free cash flow yield above 4% Free cash flow of 18.6B is 1.7% of the market value.
Growth 4 of 5
- Passed:Revenue grew over the last year Revenue of 336B is +3.2% on the year before.
- Passed:Revenue grew more than 5% a year over five years +12.1% a year from FY 2021 to FY 2026.
- Failed:Earnings per share grew over the last year EPS 51.42 against 67.78 in the year before.
- Passed:Earnings per share grew more than 5% a year over five years +20.0% a year from FY 2021 to FY 2026.
- Passed:Analysts expect higher earnings per share over the next year The average forward estimate is +84.1% on the last 12 months.
Profitability 2 of 5
- Passed:Profitable over the last year Net income of 42.9B over FY 2026.
- Passed:Profitable in each of the last five fiscal years A profit in 5 of the last 5 fiscal years.
- Failed:Return on equity above 15% Return on equity of 12.1%.
- Failed:Net margin above its 5-year average Net margin of 12.8% against a 5-year average of 15.9%.
- Failed:Free cash flow is at least 80% of net income Free cash flow of 18.6B is 43.5% of net income.
Financial health 5 of 5
- Passed:Short-term assets cover short-term liabilities Short-term assets of 302B against short-term liabilities of 168B.
- Passed:Short-term assets cover long-term liabilities Short-term assets of 302B against long-term liabilities of 31.3B.
- Passed:Net debt under 40% of equity More cash than debt: 87.8B of cash against 77.3B of debt.
- Passed:Operating cash flow covers at least 20% of debt Operating cash flow of 56.8B is 73.4% of debt.
- Passed:Operating profit covers interest at least 3 times Operating profit is 15.8 times the interest expense.
Dividend 4 of 5
- Passed:Pays a dividend 6.66B paid over FY 2026.
- Failed:Yield above 1.5% A yield of 0.6% at the current market value.
- Passed:Pays out under 75% of profit 15.5% of net income is paid out.
- Passed:Covered by free cash flow 35.7% of free cash flow is paid out.
- Passed:Not cut in the last five fiscal years The total paid did not fall in any of the last five fiscal years.
Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell. Amounts are in the company’s reporting currency.
Included in Essentials and up
Sign in to see Fair value
Discounted cash flow estimates against the price, and the P/E against its industry and sector.
Included in Essentials and up
Sign in to see Head count and owner earnings
Employees by annual report and the cash the business earns for its owners.
Included in Essentials and up
Sign in to see P/E against peers
The price to earnings ratio beside the closest competitors and their median.
Financial position
What RDY owns and owes, as of Mar 31, 2026
Short term and long term
Balance sheet · 579B of assets
Debt, equity and cash by year
Now: 10.5B more cash than debt
Fiscal years. Cash includes short-term investments.
From the company’s SEC filings, in its reporting currency.
Included in Essentials and up
Sign in to see Cash flow and returns
How profit turns into free cash flow, and the returns on equity, assets and capital.
Financial health
Altman Z-Score
5.67 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
B3 / 5 overall
- DCF 3
- Return on Equity 3
- Return on Assets 4
- Debt / Equity 3
- P/E 1
- P/B 3
Valuation
Profitability
Growth (YoY)
Financial Health
Dividends
Annual · latest fiscal year ends 2026-03-31
